Shall we call them “telomere-mediated”? Renaming the idiopathic after the cause is found

Samantha J. Merck, Mary Armanios

Source: Eur Respir J 2016; 48: 1556-1558
Journal Issue: December

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Samantha J. Merck, Mary Armanios. Shall we call them “telomere-mediated”? Renaming the idiopathic after the cause is found. Eur Respir J 2016; 48: 1556-1558

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What's it like to live with idiopathic pulmonary fibrosis? Ask the experts
Source: Eur Respir J 2016; 47:1324-1326
Year: 2016


To tracheostomize or not to tracheostomize?
Source: Eur Respir J 2005; 26: Suppl. 49, 393s
Year: 2005

Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
Source: Eur Respir J, 53 (5) 1900615; 10.1183/13993003.00615-2019
Year: 2019



Neutrophilic inflammation: "Don't you go to pieces on me!"
Source: Eur Respir J 2006; 28: 257-258
Year: 2006


Cough dysfunction: What to measure? When to treat?
Source: Annual Congress 2008 - PG19 - Ventilatory management and cough enhancement in patients with neuromuscular disease
Year: 2008



Can we diagnose ILD ? - Yes, we can! Interactive cases
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Can we diagnose ILD ? - Yes, we can! Interactive cases
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Patient testimony: hyper-IgE ?syndrome and associated lung ?infections
Source: Breathe, 15 (4) e131; 10.1183/20734735.0331-2019
Year: 2019



Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
Source: Eur Respir Rev 2015; 24: 375-377
Year: 2015


Don't forget about neuromuscular disorders!
Source: Eur Respir J, 52 (3) 1801657; 10.1183/13993003.01657-2018
Year: 2018



Genetic variation and common diseases. Where are we? Where to go?
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008



Persistent atelectasis: then what?
Source: Annual Congress 2010 - Paediatric Grand Round: an interactive session
Year: 2010


What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease?
Source: Research Seminar 2007 - Severe Asthma
Year: 2007


Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?
Source: Eur Respir J, 53 (2) 1800994; 10.1183/13993003.00994-2018
Year: 2019



Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?
Source: Eur Respir J, 53 (2) 1801939; 10.1183/13993003.01939-2018
Year: 2019



Treating inflammation: should we bother?
Source: International Congress 2017 – Cystic fibrosis in children and adults: treatment dilemmas
Year: 2017


What's in a name? That which we call IPF, by any other name would act the same
Source: Eur Respir J, 51 (5) 1800692; 10.1183/13993003.00692-2018
Year: 2018